• Pacific Software is a development technology innovator focused on facilitating greater trade between China and Latin America
• The company is preparing to take import industry subscribers for its new BOAPIN blockchain-based trade solution
• The company’s virtual technological Silk Road will initially link China and Brazil import/exports, with eye on expansion through Latin America
• BOAPIN is designed for trade transparency to facilitate solutions across international borders

Emerging business development technology innovator Pacific Software Inc. (OTC: PFSF) announced earlier this month that its anticipated e-commerce platform for international transactions, known as BOAPIN, will soon begin to register new buyers and sellers as it builds a virtual Silk Road for trade between China and South America.

“As global economies explore strategies to improve cross-border data infrastructure, Pacific Software is creating smart contract technology that integrates important functionalities for seamless global supply chain management,” Pacific Software CEO and Chairman Harrysen Mittler stated in the January 3 news release (http://ibn.fm/EmGrY).

Pacific Software’s mission is to enable global trade expansion by creating a technological portal that crosses borders and allows buyers and sellers to work seamlessly and transparently without being stymied by barriers of language, distance or regulations. BOAPIN is designed to improve how product movement through the supply chain is traced so its subscribers can manage quality and certification issues. The smart contract technology also provides solutions that facilitate data collection and analysis, marketing, searches for specific commodities, payments across borders and customs clearance.

The company is focused on building its virtual Silk Road between China and Brazil, the largest countries on their respective continents but half a world away from each other geographically. China is an increasingly international player (http://ibn.fm/fb7sl), as evidenced by its recent efforts to practically corner the market on critical components in the lithium-ion batteries that power the majority of the world’s computer products.

A heightened trading partnership between Brazil and China through a proprietary Pacific Software platform at a time when the United States is questioning its dominant trade relationship with China could strengthen Brazil’s already $40 billion yearly pipeline (http://ibn.fm/A50jt). Once it is in place, Pacific Software could use it as a springboard for lengthening the virtual Silk Road to other areas of South America.

Pacific Software co-sponsored the Latin America Night event at the 124th session of the Canton Fair PDC (Product Development Council) Design Show in Guangzhou, China, in November to foster potential networking relationships between government officials and businesses (http://ibn.fm/oYaLs). The company also represented itself at the China International Import Expo in Shanghai.

The technological wizardry of BOAPIN is due to the contributions of IBM’s Hyperledger Blockchain Backend as a Service (BaaS) infrastructure. The platform tracks, records and stores digital product information by integrating blockchain components, and it is accessible via a variety of channels linked into the Internet of Things.

“Reassurance regarding the provenance, safety and quality of products delivered may save exporters significant time and resources in the event a product becomes subject to recall,” the company stated in a news release issued on November 29 (http://ibn.fm/m85In). Through the use of the company’s blockchain-based solution, “an error free, tamper proof record covering the entire supply chain may be provided which could pinpoint the precise origin of any contamination, thereby enabling a narrow, focused and efficient recall of the affected products.”

For more information, visit the company’s website at www.PacificSoftwareInc.com

• Planting at the Scio project in Oregon can begin in late May or early June, extending the growing season by 45 to 60 days
• The project has already received Oregon Department of Agriculture registration to cultivate hemp in 2019
• Company will cultivate three different strains of hemp, characterized by high CBD content and a very low THC level

Marijuana Company of America Inc. (OTCQB: MCOA), an innovative hemp and cannabis corporation, announced on January 10 that clone production at the Scio, Oregon, high yielding CBD hemp project is underway. MCOA and joint venture partner Global Hemp Group Inc. (OTC: GBHPF) (CSE: GHG) (FRANKFURT: GHG) are preparing to begin planting as early as possible in 2019, which will have a positive effect on the length of the growing season (http://ibn.fm/ilRRX).

In 2018, MCOA had a late start because of delays in finalizing the acquisition of the Scio property – a 109-acre farm to cultivate high yielding CBD hemp. The property is located in the fertile Willamette Valley that has a history of hemp cultivation.

According to plans, planting can begin in late May or early June this year. As a result, MCOA will lengthen the growing season by 45 to 60 days. The additional time will allow for the plants to grow considerably larger and to generate a significantly larger quantity of biomass in comparison to 2018.

The company will cultivate three strains of hemp at the Scio project this year. All three strains are characterized by high CBD content, ultra-low levels of THC and substantial biomass yields. Additionally, the selected strains have superior pest resistance and a shorter flowering period, enabling earlier harvest.

The hardiest phenotypes will create the mother plants that will be in the heart of the cloning process. MCOA started the cloning process in November 2018, soon after the completion of the annual harvest and drying operation. As a result of the cloning operation, MCOA expects to have approximately 40,000 plants that will be needed for the lower 35 acres of the farm.

MCOA is also working on expanding the scope of the cloning operation. The Scio project team is upgrading both the light and the electrical systems in the property greenhouses. According to preliminary estimates, cloning operations are projected to produce a greater number of plants than what’s required for the farm.

Getting the cloning project underway has an added benefit for MCOA; it eliminates the need for the purchase of clones produced by third-party growers. In 2018, the company had to adopt such an approach, which contributed to operating expenses of more than $200,000 due to the late acquisition of the property. There was not time to produce enough clones for the 2018 crop.

Covered Bridge Acres (“CBA”), the project operating company, has already received Oregon Department of Agriculture registration to cultivate hemp in 2019. In addition, CBA has a permit to produce and handle agricultural hemp seed, which means that a seed breeding program can be established.

MCOA specializes in the production and development of legal hemp-derived CBD products under the hempSMART™ brand. The brand targets general health and wellbeing.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

• SinglePoint recently launched Phyto-Bites product to help pets – particularly dogs – deal with stress, pain and separation anxiety
• The company anticipates building on its vertical acquisition strategy in 2019 to capitalize on federal hemp legalization
• Market forecasts anticipate U.S. pet industry expenditures, which would include therapeutic products, to more than double within the next few years

Pet owners looking for natural therapies to help their four-legged loved ones through bouts of pain and anxiety are gaining an increasing array of options as the cannabis revolution opens the doors to new product research, including therapeutics for animals. Now, SinglePoint Inc. (OTCQB: SING), a diversified holding company specializing in M&A activity that promotes new technologies, finds itself among a competitive field that’s wild about cannabidiol (CBD) therapeutics for pets as cannabis legalization continues to advance, as noted in a report by Investorideas.com (http://ibn.fm/Mmyyx).

SinglePoint subsidiary SingleSeed.com recently launched its Phyto-Bites product as a brand formulated to reduce stress, pain, separation anxiety and inflammation – particularly for dogs. The company is working with manufacturer CBD Unlimited (formerly Endexx) to distribute the product online and in stores across the nation.

“We are very excited to add this to our list of products. The pet market is a tremendous opportunity and we plan to attend and use all our contacts to promote this product at every opportunity we are presented with,” SinglePoint CEO Greg Lambrecht stated in the report.

“We love our pets. Raising pets like they are members of our families means we go the extra mile for them. Especially when it comes time to address their health problems,” the company states in its blog (http://ibn.fm/DOzsT). “More and more pet owners are turning to CBD to help their buddies in similar fashions.”

The Investorideas.com report cites forecasts from the American Pet Products Association and New Frontier Data predicting that U.S. pet industry expenditures will grow from over $72 billion last year to $202.6 billion by 2025, with a five-year CAGR of 57 percent by 2022.

The states’ rights movements of recent years led to a spreading legalization of “medical marijuana” and, in a few cases, recreational drug use, despite federal drug policy outlawing it. The movement was emboldened when a cannabis-based pharmaceutical received federal Food and Drug Administration approval last year, and then Congress passed legislation allowing hemp to be grown commercially in the United States without drug control oversight, even though the FDA continues to require regulatory oversight for CBD use in food products.

“Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, but also can put patients at risk, as these products have not been proven to be safe or effective,” FDA Commissioner Scott Gottlieb stated in a release (http://ibn.fm/Hh735). “At the same time, we recognize the potential opportunities that cannabis or cannabis-derived compounds could offer and acknowledge the significant interest in these possibilities. We’re committed to pursuing an efficient regulatory framework for allowing product developers that meet the requirements under our authorities to lawfully market these types of products.”

SinglePoint is exploring opportunities to produce industrial hemp through joint venture opportunities with agricultural growers. The company has also placed an investment in a program that would grow hemp strains of CBD in a photobioreactor as an initiative to reduce the cost and time involved in making a potentially pharmaceutical-grade product.

“We are excited for these new opportunities in the hemp market and have been preparing the company to be in a position in the event the 2018 Farm Bill passed. Now that it has, it’s a matter of closing on the negotiations we have started,” Lambrecht stated in December (http://ibn.fm/80ZRw). “I intend and plan for SinglePoint to be a key player in the distribution of hemp products and sourcing the best products we can in the market.”

“2019 will be a banner year for SinglePoint we are equipped with the proper funding, partners and opportunities to be firing on all cylinders,” he added on January 10 (http://ibn.fm/aSHqc). “We as a team expect to position SingleSeed and SinglePoint as market leads in the CBD market while continuing to enable founders of the companies we have acquired to grow their businesses.”

For more information, visit the company’s website at www.SinglePoint.com

• Lexaria Nicotine LLC partners with one of the world’s largest tobacco companies
• Opportunity to change nicotine delivery and improve the lives of millions
• Retains ownership of DehydraTECH while licensing the technology out to multiple industries

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has partnered with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH (http://ibn.fm/YwFuE). The partnership may potentially commercialize this cutting-edge technology for oral nicotine delivery.

Chris Bunka, CEO of Lexaria Bioscience, is excited about the opportunity to work with a world-class partner. In a recent press release, Bunka stated, “Together we have the opportunity to change nicotine delivery and make a difference in the lives of millions of consumers.”

Lexaria’s goal is to create an oral product that eliminates the need for inhalation and helps curb the smoking habits of consumers. Over six million deaths a year worldwide are attributed to nicotine delivery through smoking. The company believes that its DehydraTECH technology may help the 69 percent of U.S. adult smokers who want to quit move from cigarettes to a safer, more effective delivery of nicotine (http://ibn.fm/Aps9F). This new partnership allows for further research and development into oral, reduced-risk nicotine consumer products.

In exchange for a minority equity interest in Lexaria’s nicotine subsidiary, the partner will fund up to $12 million through multiple phased private financings for Lexaria Nicotine LLC to conduct further research and development. Assuming nicotine products using DehydraTECH become available to consumers, Lexaria Nicotine will receive a royalty on revenue generated. The partner has been given exclusive license rights to commercialize oral nicotine products in the United States and nonexclusive rights for global commercialization. The partner also holds the option to acquire ownership of the subsidiary and has the right to appoint one of seven directors to the subsidiary’s board of directors, with the potential to appoint additional directors in the future.

Lexaria has created a number of individual subsidiaries, such as Lexaria Nicotine, that allow the company to retain ownership of DehydraTECH technology and license its use to multiple industries. This innovative oral technology improves the taste, smell, rapidity and delivery of bioactive compounds, which allows for the delivery of substances within edible food products rather than the traditional unhealthy practice of smoking.

DehydraTECH works as an enabling technology rather than a competing one, thereby allowing partnerships within multiple industries. Currently, the technology is patent protected for cannabidiol and all other non-psychoactive cannabinoids. Patents are pending for THC, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine, other psychoactive cannabinoids and other molecules. Lexaria has a total of 10 patents issued with over 50 more pending.

For more information, visit the company’s website at www.LexariaBioscience.com

• ETST gives Forzagen exclusive distribution rights for its high-grade, full-spectrum cannabinoids in all Latin American countries
• ETST chairman says that partnership will give company additional exposure and revenue as products are sold in new territories
• SeeThruEquity projects that ETST will achieve $7.1 million in revenues by 2020 as it grows distribution of CBD product line

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, as well as medical devices and hemp cannabinoid (CBD) products, has partnered with premium dietary supplement provider Forzagen to distribute ETST’s line of cannabinoids throughout Mexico and South America (http://ibn.fm/OnLqW).

As part of the agreement, Forzagen will be given exclusive rights to distribute ETST’s high-grade, full-spectrum cannabinoids in all Latin American countries. Forzagen’s distribution includes retailers such as Sam’s Club and Petco.

The partnership marketing, to be launched in the future, calls for Forzagen to distribute three ETST products: High Grade Full Spectrum Cannabinoids–Raw (.05 oz.), High Grade Full Spectrum Pet Cannabinoids–Raw (1oz.) and High Grade Full Spectrum Cannabinoids Veggie Caps.

ETST, based in Doral, Florida, says that it will collaborate with Forzagen on the linguistics of product labels and marketing in each Latin territory within the distribution network. “Powered by ETST” will be on the Spanish packaging to ensure that consumers are informed about the highly effective quality of the company’s cannabinoids.

“This partnership is an amazing opportunity for us to tap into fresh territories through Forzagen’s established distribution network,” ETST Chairman Nickolas S. Tabraue stated in a news release. “We expect to gain great exposure and additional revenue through this strategic partnership.”

ETST sees FY2019 as a pivotal expansion year. SeeThruEquity projects that ETST’s diverse activities will enable the company to reach revenues of $7.1 million by 2020 (http://ibn.fm/5ANRl).

For more information, visit the company’s website at www.EarthScienceTech.com

• Icon plans to operate in both medical and recreational cannabis markets
• Preparation of 40,000-square-foot resource in Brantford, Ontario, underway
• Recreational marijuana market forecast to record CAGR of 77.9 percent from 2018 to reach $3 billion in 2021

What may be a tough call in horseracing is much easier in Canada’s cannabis market. The odds of choosing both the winner and the second-place finisher in any race – an exacta – are never good, but, for Icon Exploration Inc. (TSX.V: IEX.H), the probability of picking winners in Canada’s cannabis market is decidedly better. In what is a win-win situation for Icon, the company has placed bets on both recreational and medical cannabis. This legal market is growing at double-digit rates, and, capitalizing on that growth, Icon is aiming to create a well-diversified company that produces long-term returns for shareholders. To do so, it intends to be a leading purveyor of medicinal and recreational cannabis, while, at the same time, providing the most comprehensive and customer-centric user experience for both patients and consumers.

It has already embarked on that enlightened mission. Icon’s strategy has begun with a foray into medical cannabis, and it plans to capture and market that theme of wellness and good health garnered from marketing medicinal marijuana as it sets about its recreational cannabis operations. The company is finalizing its acquisition of City View Green (“CVG”), a vertically integrated cannabis company. CVG has submitted an application to Health Canada for a producer license under Access to Cannabis for Medical Purposes Regulations (ACMPR), which is currently in the in-depth review stage.

CVG is in the process of preparing a 40,000-square-foot resource in Brantford, Ontario, about half of which will be converted into a modern greenhouse. Pending receipt of the license, this facility will produce pharmaceutical-grade cannabis. CVG has engaged experienced contractors with extensive experience in the pharmaceutical and medical cannabis space to manage the process. The grow area will have state-of-the-art LED lighting, HVAC and dehumidification systems and automation technologies designed to optimize the quality, safety and consistency of cannabis production. A 4,000-square-foot extraction laboratory is also on the drawing board; initially, it will employ an ultra-efficient CO2 supercritical extraction process and, subsequently, ethanol extraction technology.

Production will be marketed through an associated distribution channel that CVG is in the process of setting up. The company has signed an agreement with a retailer that has applied for 37 cannabis licenses in Alberta. The agreement provides that, on closing, each company will receive an equity interest equal to 19.99 percent of the other. The deal essentially creates a vertically integrated entity, with guaranteed supplies for retailing and a ready market to which production can be dispatched.

CVG believes that it has assembled an experienced team that can deliver on its business plan. The company has secured a master grower with cannabis-industry experience to attend to indoor grow operations and has identified both a quality assurance manager and head of security. CVG has also retained an extraction expert from the Seattle, Washington, cannabis market, who has amassed significant expertise in developing and launching new products from extractions. In addition, the company plans hires with strong experience in the alcohol and beverage industry.

Winning in the Canadian cannabis market should be a piece of cake. The Canadian government projects that 450,000 customers a day will participate in the cannabis market, making recreational cannabis in Canada a $900 million industry. It expects initial market demand to be 100,000 kg, and users are projected to grow by more than a half million within the first three years of legal cannabis sales in the country. Adult-use spending is expected to record a rapid CAGR of 77.9 percent from 2018, reaching $3 billion in 2021.

For more information, visit the company’s website at www.IconExploration.net

• TGOD among mere handful of Canadian cannabis cultivators dedicated to organic growing principles
• Health Canada seeks public input on regulations governing upcoming legalization of edible cannabis, extracts and topicals
• Deloitte survey notes that 60 percent of Canadians plan to purchase cannabis edibles
• Company has funded capacity of 170,000 kg and is currently building three cultivation facilities in two countries
• Cannabis-infused food and beverage market in the U.S. and Canada was expected to top $1.5 billion in 2018

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a premium, organic cannabis-focused research and development company, is seeking to hasten the company’s time from harvest to sale as Health Canada assures consumers that cannabis edibles, extracts and topicals will be legal by October 2019. While medical cannabis has been available to patients for some time in Canada, adult-use recreational cannabis became legal in October 2018 with the caveat that additional cannabis products – such as edibles, topicals and extracts – would follow. Health Canada’s public comment period on the proposed regulations concludes on February 20, 2019 (http://ibn.fm/kw4Zl).

For TGOD, its newly signed royalty-bearing commercial sublicense with EnWave Corporation (TSX.V: ENW) (FSE: E4U) and Tilray, Inc. (NASDAQ: TLRY) offers the company the ability to increase its production timeline through EnWave’s proprietary Radient Energy Vacuum (“REV”) dehydration technology, according to a news release (http://ibn.fm/Sgsok). EnRay’s REV technology is an innovative method for the precise dehydration of organic materials. Tilray is a licensed partner with an exclusive right to use and sub-license EnWave’s proprietary REV technology in Canada. Under the license agreement, EnWave and Tilray will share royalties from TGOD’s use of the REV technology on an undisclosed basis.

“We are incredibly excited to utilize this proprietary and advanced dehydration technology, which will promote consistency in the manufacturing of our premium organic products, improve space efficiency by reducing the need for drying rooms and quicken TGOD’s time from harvest to sale,” TGODF Chief Executive Officer Brian Athaide stated in the news release.

Spending on cannabis-infused food and drink reached an estimated $1 billion in 2017 in the U.S. and Canada, representing around 11.4 percent of the total $9.1 billion in those two markets, and it is expected to top $1.5 billion in 2018, according to a report by Arcview Market Research in partnership with BDS Analytics (http://ibn.fm/e4WFg). Consumers are shifting toward consumables, the report states, with edibles and concentrates taking a larger share of cannabis inventory.

In a 2018 survey from Deloitte, close to 60 percent of Canadians said that they would use cannabis edibles, with overall consumption of cannabis expected to rise by up to 35 percent (http://ibn.fm/H2b2a). Canadian cannabis consumers also want better quality products, the report states, with more than half noting a preference for products that are certified free from pesticides and other harmful materials.

The $4.2 trillion wellness industry is another vertical that’s certain to benefit from Canada’s pending legalization of additional cannabis products in October, according to an article published on Yahoo! Finance (http://ibn.fm/l0fUd). TGOD is solidifying its place in that arena with a strategy focused on developing a premium, organically-grown cannabis product line.

”We believe that the beverage and edible market will be the largest single segment of the cannabis market. Cannabis, as the base ingredient, makes these products possible,” TGOD President Csaba Reider stated in the article. “The medicinal and recreational market for CBD and THC will only increase over time and starting with an organic input is the most important aspect to developing these higher margin products.”

For more information, visit the company’s website at www.TGOD.ca

• The company plans a nationwide expansion of its Where’s Weed segment and related assets
• Total sales force expected to triple so as to cover the entire U.S. market, while network of distributors and dispensaries integrated into the Where’s Weed mobile platform will also grow
• Where’s Weed’s rapid growth is coinciding with legislative changes in the U.S. that are anticipated to stimulate the significant expansion of the legal cannabis industry over the coming years

Golden Developing Solutions Inc. (OTC: DVLP), an emerging leader in the cannabis, hemp and cannabidiol (CBD) marketplace, has announced a broad nationwide expansion of its Where’s Weed platform and its primary assets – the www.WheresWeed.com website and the Where’s Weed mobile app. The online and mobile cannabis services hub enables fast and efficient discovery, as well as purchases of cannabis for both medicinal and recreational purposes.

The expansion is a result of the record-breaking transactional volume of $18 million achieved by Where’s Weed in 2018. Due to the popularity and considerable growth of Where’s Weed, the company will also triple its sales force, according to a press release issued on January 17 (http://ibn.fm/EUdRa). The aim of this expansion is to help cover the entire U.S. market and build a growing network of partner dispensaries and distributors integrated with the Where’s Weed web/mobile platform.

Where’s Weed is growing at a rapid pace, and, as the Federal Farm Bill is changing the legislative landscape in the U.S., Golden Developing Solutions is willing to work even harder on fueling that growth, as noted by CEO Stavros Triant.

Commenting on the benefits of the platform, Triant said that “as far as we know, [Where’s Weed is] absolutely the best way to guarantee that the dispensary you go to will give you the product you want. Without searching and locating the product and pre-purchasing it over the Where’s Weed mobile platform, you may waste an hour of your time and end up finding that what you want has just sold out before you get there.”

According to Golden Developing Solutions management, the powerful growth of Where’s Weed has triggered important network effect benchmarks that outline the potential for dominance in the niche of cannabis location, purchase and delivery app services online and on mobile. The implementation of a minor usage fee is currently being considered as a possibility for the monetization of the Where’s Weed platform.

Apart from announcing the successful performance of Where’s Weed, Golden Developing Solutions has also hinted at an expansion of the company’s overall presence in the legal cannabis sector. Golden Developing Solutions will be making a major addition to its core business model that will be presented over the coming weeks.

Where’s Weed was developed in 2017, with the www.WheresWeed.com website launching in 2018. Within a single year, the performance of the brand exceeded expectations, with over 76,000 separate orders placed. Golden Developing Solutions completed its acquisition of Where’s Weed at the end of September 2018.

Golden Developing Solutions is developing an online retail business for CBD, health oil and wellness-related products, offering a wide range of high-quality products via its joint venture partner, Pura Vida Vitamins (www.PuraVidaVitamins.com). In addition, the company runs its own ancillary software division (www.GreenerGrows.org), launched in 2018, which enables cannabis growers to get valuable industry information and to communicate effortlessly with each other via a digital channel.

For more information, visit the company’s website at www.GoldenDeveloping.com

• Supreme Cannabis continues to identify new opportunities to build innovative cannabis businesses
• The company’s 7ACRES subsidiary operates a 440,000 sq. ft. cultivation facility
• Supreme Cannabis’ goal is to become the leading producer of premier commercial cannabis

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) concentrates on building innovative cannabis businesses around the world. A global movement headquartered in Toronto, Ontario, Canada, the company established 7ACRES as the first licensed producer focused on growing high-quality cannabis in large quantities. The 7ACRES licensed producer subsidiary operates a 440,000 sq. ft. facility in Kincardine, Ontario. On March 11, 2016, 7ACRES was federally licensed to produce (http://ibn.fm/WOiwo).

Supreme Cannabis developed 7ACRES’ state-of-the-art greenhouse, technology and thorough cultivation practices to enable 7ACRES to grow premier cannabis sustainably and at scale. 7ACRES is the largest facility of its type to engage in growing with advanced HVAC (heating, ventilation and air conditioning) and CO2 enrichment utilizing the full-spectrum sun instead of limited-spectrum lamps. What results in the final production is indoor-quality buds with sun-grown characteristics, as the greenhouse is essentially an indoor facility with skylights.

7ACRES is on course to becoming Canada’s foremost cultivator of consistently first-rate commercial cannabis. 7ACRES leverages a customizable cultivation program and a proprietary drying technology. In addition, it features a hybrid manual finish encompassing automated trimming and hand trimming.

For early this year, the estimated production run rate at 7ACRES is 50,000 kg at full capacity. As of September 1, 2018, the annual production run rate was 13,333 kg (http://ibn.fm/d9pDN). 7ACRES concentrates on the high margin segment of the market and is listed as a premium product by all Canadian provinces.

Supreme Cannabis Company has partnerships with a number of Canadian cannabis firms (http://ibn.fm/H7BY8). These include Aurora Cannabis, Emerald Health Botanicals, Namaste and Zenabis, among others. These partners are some of Canada’s top cannabis retailers.

Supreme Cannabis also focuses on high-quality investments. The company has an equity interest and distribution agreement with Medigrow Lesotho (PTY) Limited (http://ibn.fm/3mzs0). With this distribution partnership, cannabidiol oil will be exported to Canada and other global markets in the European Union (EU) and South America.

Recently, Supreme Cannabis Company announced its reception of conditional approval from the Toronto Stock Exchange (TSX) to uplist from the TSX Venture Exchange (TSXV) and list its common shares on the TSX (http://ibn.fm/q3k22). With the completion of the final listing requirements, Supreme Cannabis Company’s common shares will be delisted from the TSXV and will begin trading on the TSX under the symbol ‘FIRE’.

In a news release, Navdeep Dhaliwal, Supreme Cannabis Company’s chief executive officer, said, “Graduating to the TSX will broaden our investment appeal and leave us well positioned to execute on our strategic imperatives for 2019, which is why we’re pleased to add this milestone to our list of accomplishments for the year.”

Supreme Cannabis Company offers investors the opportunity to grow with them as they work to identify new opportunities to build unique cannabis businesses. With a vision to become an international leader in cannabis, the company is focusing on continuous growth via research and innovation. With its 7ACRES brand named ‘Brand of the Year’ at the 2018 Canadian Cannabis Awards (http://ibn.fm/WFn55), Supreme Cannabis is positioned for new heights in the cannabis industry.

For more information, visit the company’s website at www.Supreme.ca

• Pacific Software has opened a Hong Kong office and retained an adviser to lead its operations in China
• The hyperledger systems developer expects to complete a blockchain-based software platform by month’s end to manage supply tasks
• Supply chain management is particularly crucial to the food industry, which has dealt with high-profile contamination concerns during the past year
• The company’s e-commerce portal and trade platform will also provide services in smart contracts, digital marketing and fintech

Two days before Thanksgiving, the U.S. Centers for Disease Control (CDC) issued a warning to the entire country — don’t eat romaine lettuce. For the second time this year, restaurants and grocers found themselves pressured to toss their inventory for fear it might be among the produce tainted by the E. coli bacteria, and the Thanksgiving cooks at home had to decide if they needed to do something different for salads. Emerging technology development business Pacific Software Inc.’s (OTC: PFSF) foray into blockchain-based agricultural supply chain management envisions a world in which such incidents are limited in scope, and the source of the contamination is more rapidly ferreted out.

Pacific Software is a designer and developer of hyperledger blockchain-based systems that is focusing its resources on agricultural and drug trade supply lines. The company’s farm-to-table blockchain solution aims to help the market follow the distribution of products such as heads of romaine lettuce, particularly through the use of Internet of Things (IoT) barcode or RFID technology that can allow easy application with handheld computers.

The U.S. Food and Drug Administration ultimately determined that this fall’s E. coli outbreak could be traced back to a specific Santa Maria, California, farm and potentially others, as well, according to an announcement (http://ibn.fm/qjtrJ) by the federal agency on December 13 that led the identified farm to recall three additional types of produce “out of an abundance of caution.”

The fall E. coli outbreak sickened a reported 59 people from 15 states and Washington, D.C., hospitalizing nearly half of them (http://ibn.fm/WQWVW). None died, but in the E. coli taint incident linked to romaine lettuce in Arizona between March and June of last year, five of the 210 sickened people died, and the specific farm from which the lettuce originated was never able to be identified. While the two cases do not appear to be related, the E. coli strain involved in the latest case appears to have the same genetic fingerprint as one that sickened people in the United States and Canada late last year, according to the Washington Post (http://ibn.fm/UjTki). The source of that contamination was also never identified.

“The quick and aggressive steps we’re taking today are aimed at making sure we get ahead of this emerging outbreak, to reduce risk to consumers, and to help people protect themselves and their families from this foodborne illness outbreak. This is especially important ahead of the Thanksgiving holiday, when people will be sitting down for family meals,” FDA commissioner Scott Gottlieb told the Post after the most recent romaine alert was issued.

Pacific Software is developing a multi-lingual software platform designed not only to protect the agricultural pipeline domestically from such a nationwide scare, but to safeguard the international transport of food products, as well (http://ibn.fm/F87Z4). The e-commerce portal and trading platform is scheduled for release at the end of Q1 2019, and it is expected to provide services that include blockchain solutions, smart contracts with a search interface, digital marketing and fintech applications.

The company announced on November 29 that it had opened an office in Hong Kong, and it has retained experienced investment businessman Wallace Lo to serve on its advisory board and to oversee its business operations in China (http://ibn.fm/Jb6PV).

“Reassurance regarding the provenance, safety and quality of products delivered may save exporters significant time and resources in the event a product becomes subject to recall,” the company stated in making the announcement. Through the use of its blockchain-based solution, “an error free, tamper proof record covering the entire supply chain may be provided which could pinpoint the precise origin of any contamination, thereby enabling a narrow, focused and efficient recall of the affected products.”

For more information, visit the company’s website at www.PacificSoftwareInc.com